Zinc sulfate
Zincteral is a medicinal product in the form of coated tablets for oral administration, containing zinc ions as an active substance.
Zinc is one of the most important trace elements involved in cellular metabolism. It is a component of many enzymatic systems that regulate basic metabolic processes - it participates in protein synthesis and carbohydrate metabolism. It is essential for proper growth and reproduction. Zinc is absorbed in the duodenum and small intestine.
Indications for the use of Zincteral:
Tell your doctor about all the medicines you have taken recently, including those that are available without a prescription.
The medicine is usually taken 1 hour before or 2 hours after a meal, as many food products may disrupt zinc absorption.
Food products containing phytic acid (e.g., whole grain bread) reduce zinc absorption and should be avoided after taking zinc-containing medications.
If the patient is pregnant or breastfeeding, thinks she may be pregnant, or plans to have a child, she should consult a doctor or pharmacist.
Zinc crosses the placental barrier. No studies have been conducted on the effect of usually administered doses of zinc salts on the course of pregnancy and fetal development. There are also no adequate animal studies.
The medicine may be used during pregnancy only in cases where, in the doctor's opinion, the benefit to the mother outweighs the potential risk to the fetus.
Zinc passes into breast milk. No studies have been conducted on the effect of usually administered doses of zinc salts in breastfeeding women.
It is not recommended to use the medicine during breastfeeding.
The medicine does not affect psychophysical fitness, the ability to drive vehicles, and operate machinery.
If the patient has previously been diagnosed with intolerance to some sugars, the patient should consult a doctor before taking the medicine.
The medicine may cause allergic reactions.
This medicine should always be taken exactly as directed by your doctor. If you are unsure, consult your doctor or pharmacist.
Method of administration
The medicine is taken orally.
Adults
Usually 1 to 2 tablets per day.
Wilson's disease
In adults, usually 4 tablets per day in a 1-2-1 scheme, starting with a dose of 1 tablet per day, increasing every 3 days, according to the following dosing scheme:
0-1-0 - one tablet per day
1-1-0 - two tablets per day
1-1-1 - three tablets per day
1-2-1 - four tablets per day
Children and adolescents
In children over 4 years of age and adolescents, 1 tablet per day.
The medicine is usually taken 1 hour before or 2 hours after a meal, as many food products may disrupt zinc absorption. If symptoms of gastrointestinal irritation occur, the medicine can be taken directly before or during a meal, but then the absorption of the medicine may be lower.
Do not divide or chew the tablets.
In case of taking a higher dose of Zincteral than recommended, an overdose may occur.
In case of taking a higher dose of the medicine than recommended, consult a doctor immediately.
Symptoms
Burning pain in the mouth and throat, watery or bloody diarrhea, painful defecation, belching, hypotension (dizziness); jaundice (yellowing of the eyes and skin); pulmonary edema (chest pain, difficulty breathing); vomiting. The following may also occur: hematuria, anuria, shock, seizures, hemolysis (red blood cell breakdown with hemoglobin release into the serum), fatigue.
Long-term use of zinc sulfate may cause copper deficiency.
In case of missing a dose of Zincteral, do not take a double dose to make up for the missed dose; take the next dose at the usual time.
If you feel that the effect of the medicine is too strong or too weak, consult a doctor.
Like all medicines, Zincteral can cause side effects, although not everybody gets them.
After high doses of zinc, with an unknown frequency, gastrointestinal disorders (nausea, indigestion, heartburn), blood and lymphatic system disorders (blood morphology disorders), including leukopenia (reduced white blood cell count) manifested by: fever, chills, throat pain, neutropenia (reduced granulocyte count) manifested by: oral and throat ulcers, sideroblastic anemia (anemia caused by impaired red blood cell production) manifested by: fatigue, weakness. Headaches and metallic taste in the mouth may also occur.
If you experience any side effects, including those not listed in this leaflet, please inform your doctor or pharmacist.
Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych, Al. Jerozolimskie 181C, 02-222 Warszawa, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the reach and sight of children.
Store in a temperature below 25°C.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Coated tablets, purple-pink, round, biconvex, with a uniform surface.
50 tablets (2 blisters of 25 each) in a cardboard box.
150 tablets (1 bottle containing 150 tablets) in a cardboard box.
Teva Pharmaceuticals Polska Sp. z o.o.
ul. Emilii Plater 53
00-113 Warszawa
tel.: (22) 345 93 00
Teva Operations Poland Sp. z o.o.
ul. Mogilska 80
31-546 Kraków
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.